IFNA2 and melanoma: We recently showed that peripheral blood lymphocytes (PBL) from patients with melanoma and other cancers have reduced phosphorylation of signal transducer and activators of transcription 1 (pSTAT1) upon Interferon-α (IFN-α) stimulation, demonstrating a defect in Type I IFN signaling [15,16].